Literature DB >> 2043765

The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin.

L C Wasley1, G Timony, P Murtha, J Stoudemire, A J Dorner, J Caro, M Krieger, R J Kaufman.   

Abstract

Erythropoietin (EPO) plays a critical role in stimulating the proliferation and differentiation of erythroid precursor cells. EPO is heavily glycosylated with three asparagine (N)-linked tetraantennary oligosaccharides that may contain N-acetyl-lactosamine repeats and a single serine (O)-linked oligosaccharide. EPO expressed in Chinese hamster ovary cells exhibits biologic properties and amino acid and carbohydrate composition similar to natural urinary EPO. The importance of the complex N-linked and the O-linked carbohydrate was studied by expressing EPO in cells that are deficient in UDP-galactose/UDP-N-acetylgalactosamine 4-epimerase activity. In these cells, the ability to add galactose and N-acetylgalactosamine to glycoproteins can be controlled by the addition of these sugars to the culture medium. The results demonstrate that a block in O-linked glycosylation and/or the ability to process N-linked carbohydrate to completion does not alter EPO secretion. EPO produced without O-linked carbohydrate exhibits normal in vitro and in vivo biologic activity and in vivo clearance. However, EPO produced with incompletely processed N-linked oligosaccharides exhibits normal in vitro activity but is at least 500-fold less effective in stimulating erythropoiesis in vivo. Studies on the survival of bioactive EPO remaining in the circulation demonstrated that EPO with incomplete N-linked oligosaccharides exhibits a sevenfold increased rate of clearance. However, this increased clearance may not fully account for the 500-fold loss of in vivo activity. These results suggest a potentially important unique requirement for appropriate complex N-linked oligosaccharides for the intrinsic biologic activity of EPO in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2043765

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Study on the quality of recombinant proteins using matrix-assisted laser desorption ionization time of flight mass spectrometry.

Authors:  Guo-Hua Zhou; Guo-An Luo; Ya-Cheng Cao; Ming-Sheng Zhu
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

Review 2.  Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  BioDrugs       Date:  2010-02-01       Impact factor: 5.807

Review 3.  Oxygen delivery enhancers: past, present, and future.

Authors:  P Borrione; A Mastrone; R A Salvo; A Spaccamiglio; L Grasso; A Angeli
Journal:  J Endocrinol Invest       Date:  2008-02       Impact factor: 4.256

4.  Cloning and expression of a porcine UDP-GalNAc: polypeptide N-acetylgalactosaminyl transferase.

Authors:  A Yoshida; T Hara; H Ikenaga; M Takeuchi
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

5.  Biological and physicochemical characterization of recombinant human erythropoietins fractionated by Mono Q column chromatography and their modification with sialyltransferase.

Authors:  K Morimoto; E Tsuda; A A Said; E Uchida; S Hatakeyama; M Ueda; T Hayakawa
Journal:  Glycoconj J       Date:  1996-12       Impact factor: 2.916

6.  N-Glycosylation engineering of tobacco plants to produce asialoerythropoietin.

Authors:  Farooqahmed S Kittur; Chiu-Yueh Hung; Diane E Darlington; David C Sane; Jiahua Xie
Journal:  Plant Cell Rep       Date:  2012-02-28       Impact factor: 4.570

7.  Glycoengineering tobacco plants to stably express recombinant human erythropoietin with different N-glycan profiles.

Authors:  Farooqahmed S Kittur; Chiu-Yueh Hung; Chuanshu Zhu; Asif Shajahan; Parastoo Azadi; Michelle D Thomas; Jackson L Pearce; Clemens Gruber; Somanath Kallolimath; Jiahua Xie
Journal:  Int J Biol Macromol       Date:  2020-04-26       Impact factor: 6.953

Review 8.  Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease.

Authors:  Robert Deicher; Walter H Hörl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  Survival and proliferative roles of erythropoietin beyond the erythroid lineage.

Authors:  Constance Tom Noguchi; Li Wang; Heather M Rogers; Ruifeng Teng; Yi Jia
Journal:  Expert Rev Mol Med       Date:  2008-12-01       Impact factor: 5.600

10.  Rapid analysis of O-acetylated neuraminic acids by matrix assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  P Stehling; M Gohlke; R Fitzner; W Reutter
Journal:  Glycoconj J       Date:  1998-04       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.